Literature DB >> 7723461

Development and testing of a new measure of case mix for use in office practice.

S Greenfield1, L Sullivan, K A Dukes, R Silliman, R D'Agostino, S H Kaplan.   

Abstract

Case mix has been shown to be of critical importance in studies of effectiveness and quality of care using health outcomes. How these variables are defined, combined, and used to adjust or increase precision in tests for differences in health outcomes has been a source of controversy. Because existing measures were developed to adjust mortality and have marginal relevance for the adjustment of functional status outcomes, especially in ambulatory settings, the authors developed a measure of case (or patient) mix that is specifically designed to adjust functional status outcomes measured in office practice or out-of-hospital settings. This measure, developed as part of Type II Diabetes Patient Outcomes Research Team project, uses patients' reports of symptoms and conditions, as well as patients' ratings of symptom intensity to characterize total disease burden. It differs from other measures of case mix in lack of dependence on diagnoses. Separate measures were developed for each of 15 different disease categories (e.g., chronic lung disease) grouped by body system affected. Within each measure, questionnaire items were combined to rate the severity of that disease on a 1 to 4 scale, according to definitions provided by clinicians. A single, global measure was developed by aggregating the 15 measures, weighted according to the expected impact of each disease category on functional outcomes and disability. In a sample of 1,738 patients, significant relationships were observed between the global case mix measure and functional status, disability days, and service utilization.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7723461

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  31 in total

1.  The outcomes of outcomes and effectiveness research: impacts and lessons from the first decade.

Authors:  D Stryer; S Tunis; H Hubbard; C Clancy
Journal:  Health Serv Res       Date:  2000-12       Impact factor: 3.402

2.  The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes.

Authors:  Quyen Ngo-Metzger; Dara H Sorkin; John Billimek; Sheldon Greenfield; Sherrie H Kaplan
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

3.  Adherence to diabetes guidelines for screening, physical activity and medication and onset of complications and death.

Authors:  Yiqun Chen; Frank A Sloan; Arseniy P Yashkin
Journal:  J Diabetes Complications       Date:  2015-07-09       Impact factor: 2.852

Review 4.  Methodology, design, and analytic techniques to address measurement of comorbid disease.

Authors:  Timothy L Lash; Vincent Mor; Darryl Wieland; Luigi Ferrucci; William Satariano; Rebecca A Silliman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-03       Impact factor: 6.053

5.  Who can respond to treatment? Identifying patient characteristics related to heterogeneity of treatment effects.

Authors:  Sherrie H Kaplan; John Billimek; Dara H Sorkin; Quyen Ngo-Metzger; Sheldon Greenfield
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

6.  Older Adults Reporting More Diabetes Mellitus Care Have Greater 9-Year Survival.

Authors:  Benjamin H Han; Caroline S Blaum; Rosie E Ferris; Lillian C Min; Pearl G Lee
Journal:  J Am Geriatr Soc       Date:  2015-12-11       Impact factor: 5.562

7.  Self-reported medical morbidity among informal caregivers of chronic illness: the case of cancer.

Authors:  Youngmee Kim; Charles S Carver; Rachel S Cannady; Kelly M Shaffer
Journal:  Qual Life Res       Date:  2012-08-21       Impact factor: 4.147

8.  Consideration of comorbidity in risk stratification prior to prostate biopsy.

Authors:  Michael A Liss; John Billimek; Kathryn Osann; Jane Cho; Ross Moskowitz; Adam Kaplan; Richard J Szabo; Sherrie H Kaplan; Sheldon Greenfield; Atreya Dash
Journal:  Cancer       Date:  2013-04-25       Impact factor: 6.860

9.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186

10.  Performance of comorbidity, risk adjustment, and functional status measures in expenditure prediction for patients with diabetes.

Authors:  Matthew L Maciejewski; Chuan-Fen Liu; Stephan D Fihn
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.